US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
AERWINS Technologies Inc (EM) (AWIN) 銘柄情報

AERWINS Technologies Inc (EM) (AWIN)

0.0002

0.00

(0.00%)

終了 6月12日 5:00AM

AERWINS Technologies Inc (EM) (AWIN) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.0002

( - )

買値

0.00

売値

0.00

出来高

-

0.00 日の範囲 0.00

0.000001 52 週間の範囲 0.10

時価総額

前日終値

0.0002

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 1,814

発行済株式数

924,315

配当利回り

PER

-

1 株当たり利益 (EPS)

-14.39

歳入

-

純利益

-9.21M

AERWINS Technologies Inc. engages in redesign of single-seat optionally manned air vehicle in the United States. The company is based in Los Angeles, California. AERWINS Technologies Inc. engages in redesign of single-seat optionally manned air vehicle in the United States. The company is based in Los Angeles, California.

セクター

Technology

業界

Hardware & Equipment

本社

Los Angeles, United States

設立

-

AERWINS Technologies Inc (EM) is listed in the Technology sector of the その他OTC with ticker AWIN. The last closing price for AERWINS Technologies (EM) was US$0. Over the last year, AERWINS Technologies (EM) shares have traded in a share price range of US$ 0.000001 to US$ 0.10.

AERWINS Technologies (EM) currently has 924,315 shares in issue. The market capitalisation of AERWINS Technologies (EM) is US$184.86 . AERWINS Technologies (EM) has a price to earnings ratio (PE ratio) of 0.00.

Form SEC STAFF ACTION - SEC Staff Action: ORDER

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0.0002	0.0002	0.0002	232	0.0002	CS
4	0	0	0.0002	0.0002	0.0002	415	0.0002	CS
12	0	0	0.0002	0.0002	0.0002	526	0.0002	CS
26	0	0	0.0002	0.0002	0.0002	788	0.0002	CS
52	0	0	0.0002	0.1	1.0E-6	1782	0.00026917	CS
156	-0.8848	-99.9774011299	0.885	1.8	1.0E-6	9284	0.42687914	CS
260	-0.8848	-99.9774011299	0.885	1.8	1.0E-6	9284	0.42687914	CS

AWIN - Frequently Asked Questions (FAQ)

What is the current AERWINS Technologies Inc (EM) share price?

The current share price of AERWINS Technologies Inc (EM) is US$ 0.0002

How many AERWINS Technologies Inc (EM) shares are in issue?

AERWINS Technologies Inc (EM) has 924,315 shares in issue

What is the market cap of AERWINS Technologies Inc (EM)?

The market capitalisation of AERWINS Technologies Inc (EM) is USD 184.86

What is the 1 year trading range for AERWINS Technologies Inc (EM) share price?

AERWINS Technologies Inc (EM) has traded in the range of US$ 0.000001 to US$ 0.10 during the past year

What is the PE ratio of AERWINS Technologies Inc (EM)?

The price to earnings ratio of AERWINS Technologies Inc (EM) is 0

What is the registered address of AERWINS Technologies Inc (EM)?

The registered address for AERWINS Technologies Inc (EM) is The Walnut Building, Los Angeles, California, 90021

Which industry sector does AERWINS Technologies Inc (EM) operate in?

AERWINS Technologies Inc (EM) operates in the Hardware & Equipment sector

CA Market News

CA Market News 3分前

Kenorland Receives Notice of Exercise of Top-Up Right from Sumitomo and CenterraJune 12, 2026 7:30 AM
NewsfileVancouver, British Columb

gladeshawk

gladeshawk 3分前

I agree. The caveat is that there could be bad news, but that's the bet. TWT. HAWK

thetinman

thetinman 3分前

PLEASE show me where I stated PTOP should not post in social media.🙄

Your responses to my factual posts as pathetic as PTOP’S social media presence and stock price. 🤣

Btw — I'm really hoping this new promotional 'New poster(s)' campaign actually gets m

CA Market News

CA Market News 3分前

Britannia Life Sciences Announces $5.3 Million Acquisition of Commercial Equipment Loan PortfolioJune 12, 2026 7:30 AM
Newsfile

US Market News

US Market News 3分前

Baidu's Apollo Go Expands European Footprint as AmiGo, in Partnership with PostBus, Receives Level 4 Regulatory Approval in SwitzerlandJune 12, 2026 7:47 AM
PR Newswire (US) AmiGo, an on-demand autonomous mobility service between Baidu'

docj

A little more info on yesterday's news:

https://www.clinicaltrialvanguard.com/news/cytodyn-starts-phase-2a-trial-of-leronlimab-in-early-alzheimers-disease/

CytoDyn Starts Phase 2a Trial of Leronlimab in Early Alzheimer’s Disease
ByJon Napitupulu June 12, 2026

SovereignNinja5

SovereignNinja5 5分前

Thanks to DMC for providing a link to an Amarin funded study that says Sarissa/Torok/Berg are failures. The sales Rep on linked in confirms they intentionally don’t sell the drug is just the icing on the cake. Keep contacting IR for the share buybacks and having them explain themselves. The hypocris

ihubstockmover

ihubstockmover 6分前

$DBGI stock is making headlines following massive insider purchases from CEO Hil Davis, who bought $700,000 worth of company shares on the open market to demonstrate long-term confidence in the brand's growth and path to profitability. #marketscreener #tradingview

Tahoe2468

Tahoe2468 7分前

DFNS DFNS DFNS TODAY PLAY

Nelson2

Nelson2 10分前

A R/S is coming. And yes there is always a unicorn but vast majority are negative to shareholders I’m out, but good luck to you

WHITTENHALLJR

WHITTENHALLJR 10分前

Hopefully not here lol

Homebrew

Homebrew 10分前

😆 🤣 😂. That video is pathetically cringe.

Lime Time

Lime Time 11分前

No one to contest and zero debt. Should get scooped up rather quickly at NV SoS 🚀

thetinman

thetinman 12分前

You can't dispute any of the facts I've posted!
Typical. You get emotional the moment PTOP facts come up. Have you tried crying harder about my posts?

Btw — please SHOW me where I'm wrong about the lack of social media engagement and the stock price. I could post a picture of

Homebrew

Homebrew 12分前

QSEP's "rinse-repeat" PR dept's getting desperate. Their recycled, stale nonsense isn't working. This insider enrichment scheme isn't fooling anyone.

dexprs

dexprs 13分前

OT: my first Monarch butterfly raised from an egg on his new native food was born and took flight, yesterday, the first in over a year since I changed from tropical milkweed to native. The native has a much lower odds of causing OE spores and a crippling disease to butterflies.

Aquahoya

Aquahoya 13分前

$FITY Something is coming down the pike. Decent volume today. Possible biotech merger if the new CEO plans to merge his company that has $10,000,000 undiluted funds.

$FITY had the cash to eat 600+ million shares at some price and cancel them before it hitting the market.

fink

Let the broke County DA subpoena I-hub for my info. I’ll be happy to take some heat off cohen. Make it about me. I’m cool with that. I still got your money.
She can’t afford to create a case against Cohen let alone a few mean tweets. But maybe she will get a few clicks for her algo.

12yearplan

12yearplan 14分前

ALM 17.79 pm
ALM 12% day. $17.07.

Investor082

Investor082 15分前

Exactly. The data is not convincing to say the least. Therefore, the best case scenario is restricted label and no reimbursement support for a couple of years.

It wouldn’t be surprising if the stock gets slammed on the news given how long this has taken and the history of NWBO in ter

NeWBrO

NeWBrO 16分前

Wow ! Unusual spread appearing in the pre-market OTC quote …
NWBO REAL-TIME LEVEL 2 QUOTE 6:44a on 6/12/26
0.0001 / 2,000.00 (10000 x 1)

bwmg

https://www.otcmarkets.com/stock/BWMG/news/Brownies-Marine-Group-and-Mountains-to-Seas-to-Showcase-Awake-Electric-Surfboards-at-Atlanta-Foil-Fest?id=524719

Green Leaf Smoker

Green Leaf Smoker 18分前

No magic kiss gonna wake up this POS PLAY MJNA as it's been declared dead for quite some time

Well I'll be damned MJNA goes down! Here's the BEAR link to POS MJNA ....Enough Said
https://investorshub.advfn.com/stock-market/USOTC/medical-marijuana-id-MJNA/trades#google_vig

t1215s

t1215s 19分前

Changnoi
Next comes the D. 4’s🤭😏😂
https://youtu.be/_zOjRlVpAOQ

Heck I would do the same with the freebies 🤭😏

GLTA-Ts🍻😎🇺🇸

Rattlershehe

Rattlershehe 19分前

As of March, there were approximately 154 million shares, as of today a little over 221 million so that’s about 70 million shares in three months. They need 42 million to close the deal. Doesn’t have to all be cash it can be shares however they need shareholder approval to give them those shares als

AERWINS Technologies (EM)

Benchmark Healthcare Rea...

VVSTOXX November 2023

Goldex Resources

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。